You Searched For:
475 results were found
~~A18L14A UHP SEC analysis of biosimilars~~
/it.vwr.com/it_IT/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-se.vwr.com/sv_SE/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
An Overview of Restriction Enzymes
/cms/en/restriction_enzymes
Restriction Enzymes: An Overview Restriction Enzymes: An Overview It will also discuss the applications of restriction enzymes in molecular biology and biotechnology and the potential limitations when working with these enzymes. See products range...
An Overview of Restriction Enzymes
/cms/restriction_enzymes
Restriction Enzymes: An Overview Restriction Enzymes: An Overview It will also discuss the applications of restriction enzymes in molecular biology and biotechnology and the potential limitations when working with these enzymes. See products range...
Understanding monoclonal antibody aggregate behaviour impacting chromatographic process efficiency
/cms/understanding_monoclonal
Understanding monoclonal antibody aggregate behaviour impacting chromatographic process efficiency Webinar On demand Replay As titer from upstream increases capacity of the resins is more of important factor to drive process efficiency and impurit...
A18L14A UHP SEC analysis of biosimilars
/m-fi.vwr.com/fi_FI/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-be.vwr.com/nl_BE/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-be.vwr.com/fr_BE/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-nl.vwr.com/nl_NL/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-ni.vwr.com/en_NI/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-cz.vwr.com/cs_CZ/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
Understanding monocl
/store/externalContent/understanding_monoclonal
Understanding monoclonal antibody aggregate behaviour impacting chromatographic process efficiency Webinar On demand Replay As titer from upstream increases capacity of the resins is more of important factor to drive process efficiency and impurit...
~~Understanding monoclonal antibody aggregate behaviour impacting chromatographic process efficiency~~
/cms/6417901F9E9B4886886AE60F2C984AFE
Understanding monoclonal antibody aggregate behaviour impacting chromatographic process efficiency Webinar On demand Replay As titer from upstream increases capacity of the resins is more of important factor to drive process efficiency and impurit...
Understanding monoclonal antibody aggregate behaviour impacting chromatographic process efficiency
/cms/understanding_monoclonal
Understanding monoclonal antibody aggregate behaviour impacting chromatographic process efficiency Webinar On demand Replay As titer from upstream increases capacity of the resins is more of important factor to drive process efficiency and impurit...
RANKEM GC standard-Anniversary offer
/cms/gc_anni_sp
RANKEM GC standard-Anniversary offer Lets celebrate Rankem GC standard Launch Anniversary Buy any of the below GC standard @ 40 % discount Rankem offers a wide range of GC standards for chromatographic and analytical applications & allows the anal...
1 - 16 of 475